P539: A PHASE 1 STUDY OF HMPL-306, A DUAL INHIBITOR OF MUTANT ISOCITRATE DEHYDROGENASE (IDH) 1 AND 2, IN PTS WITH RELAPSED/REFRACTORY MYELOID HEMATOLOGICAL MALIGNANCIES HARBORING IDH1 AND/OR 2 MUTATIONS

Bibliographic Details
Main Authors:	Lijuan Hu, Wei-LI Zhao, Wen Wu, Xudong Wei, Ruihua MI, Yu Hu, Qiubai LI, Wenjuan He, Juan LI, Yugang Dong, Hehua Wang, Xuhan Zhang, Yu Zhang, Zhongyuan Xu, Hui Liu, Zhen Cai, Jie Sun, Yajing Xu, Zhiping Jiang, Cheng Zhang, Guo Chen, Tiejun Gong, Qinghua Tang, Hongmei Jing, Lan MA, Sujun Gao, Qiqi Liu, Zeyu Zhong, Yongxin Ren, Jian Chen, Songhua Fan, Michael Shi, Weiguo Su, Xiaojun Huang
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000969064.86312.d3

Internet